The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from UC San Francisco that offers potential clues to why some ...
Mar 7, 2024
0
597
Over the past decade or so, scientists have amassed an impressive arsenal of weapons to address the multifaceted, complex challenge of mental illness, from new genomic analysis tools and high-resolution neuroimaging technologies, ...
Feb 26, 2024
0
45
Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines. They're easy to produce precisely. They're safe and potentially more effective. And they ...
Feb 23, 2024
0
39
It was a last-ditch effort. For years doctors had tried to keep a patient's recurrent drug-resistant bacterial blood infection at bay, but it kept coming back and antibiotics were no longer working.
Feb 14, 2024
0
13
A team of medical researchers with affiliations to British multinational pharmaceutical and biotechnology company GlaxoSmithKline (GSK) has found that a new antibiotic drug the company developed to treat urinary tract infections ...
Monash University-led research is using math to predict how new combination therapies can help patients with breast cancer who no longer respond to conventional therapies.
Feb 5, 2024
0
38
A combination of two cancer drugs could be effective against malignant peripheral nerve sheath tumors (MPNSTs)—soft tissue tumors that are stubbornly resistant to chemotherapy and radiation—according to a laboratory study ...
Jan 31, 2024
0
59
A new treatment shows promise against the deadly neurodegenerative disease ALS, a study based on mice showed Tuesday.
Jan 31, 2024
0
85
A team of international researchers, led by UC San Francisco, has completed the first large-scale study of posterior cortical atrophy, a baffling constellation of visuospatial symptoms that present as the first symptoms of ...
Jan 22, 2024
0
43
Chimeric antigen receptor T-cell therapy, or CAR T, has dramatically improved the treatment of certain blood cancers. Initially approved for patients who had failed multiple lines of therapy, clinical trials have shown CAR ...
Jan 17, 2024
0
36
